Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2005 The Evangelizing Patient, Commentary 1 J. Wesley Boyd, MD, PhD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505. Case and Commentary May 2005 The Evangelizing Patient, Commentary 2 John Dunlop, MD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505. Case and Commentary May 2005 The Evangelizing Patient, Commentary 3 Harold G. Koenig, MD, MHSc Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. Policy Forum Jun 2015 Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates Michael Krawitz The new Veterans Health Administration policy on the use of medical marijuana was brought about by patient advocacy in 2010. AMA J Ethics. 2015;17(6):558-561. doi: 10.1001/journalofethics.2015.17.6.pfor2-1506. Case and Commentary Dec 2009 The Challenges of Treating Patients with Multiple Diagnoses R. Douglas Bruce, MD, MA, MSc Strategies for designing treatment programs for patients with triple diagnoses—HIV, schizophrenia, and opioid dependence. Virtual Mentor. 2009;11(12):944-948. doi: 10.1001/virtualmentor.2009.11.12.ccas3-0912. Case and Commentary Mar 2008 Duty to Warn and Dissociative Identity Disorder Michael A. Norko, MD How to treat a patient with a dissociative identity disorder and how to manage a threat made by one of the patient's personalities. Virtual Mentor. 2008;10(3):144-149. doi: 10.1001/virtualmentor.2008.10.3.ccas2-0803.
Case and Commentary May 2005 The Evangelizing Patient, Commentary 1 J. Wesley Boyd, MD, PhD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505.
Case and Commentary May 2005 The Evangelizing Patient, Commentary 2 John Dunlop, MD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505.
Case and Commentary May 2005 The Evangelizing Patient, Commentary 3 Harold G. Koenig, MD, MHSc Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Policy Forum Jun 2015 Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates Michael Krawitz The new Veterans Health Administration policy on the use of medical marijuana was brought about by patient advocacy in 2010. AMA J Ethics. 2015;17(6):558-561. doi: 10.1001/journalofethics.2015.17.6.pfor2-1506.
Case and Commentary Dec 2009 The Challenges of Treating Patients with Multiple Diagnoses R. Douglas Bruce, MD, MA, MSc Strategies for designing treatment programs for patients with triple diagnoses—HIV, schizophrenia, and opioid dependence. Virtual Mentor. 2009;11(12):944-948. doi: 10.1001/virtualmentor.2009.11.12.ccas3-0912.
Case and Commentary Mar 2008 Duty to Warn and Dissociative Identity Disorder Michael A. Norko, MD How to treat a patient with a dissociative identity disorder and how to manage a threat made by one of the patient's personalities. Virtual Mentor. 2008;10(3):144-149. doi: 10.1001/virtualmentor.2008.10.3.ccas2-0803.